June 2026
The US viral vectors and plasmid DNA manufacturing market size is valued at USD 3.30 billion in 2025 and is predicted to hit USD 11.69 billion by 2035, with a CAGR of 15.20%.
July 2026
The viral vectors and plasmid DNA manufacturing market size is expected to hit USD 29.82 billion by 2035 from USD 7.26 billion in 2025 with a CAGR of 15.17%.
May 2026
The U.S. plasmid DNA manufacturing market size was exhibited at USD 810 million in 2025 and is projected to hit USD 4,003 million by 2035, at a CAGR of 18.41%.
August 2026
The plasmid DNA manufacturing market size was estimated at USD 2.64 billion in 2025 and is expected to hit around USD 12.45 billion by 2035, growing at a CAGR of 16.78%.
September 2026
The viral and non-viral vectors market was valued at USD 9.40 billion in 2025, with leading companies including Thermo Fisher Scientific Inc., Lonza Group AG, Catalent, Inc., WuXi AppTec, Oxford Biomedica plc.
September 2026
The U.S. cell therapy manufacturing market was worth USD 1.97 billion in 2026, with key U.S. cell therapy manufacturing market players including Merck KGaA, Thermo Fisher Scientific, Catalent, Inc.
September 2026
The antiviral and antimicrobial technology market is growing with demand for advanced coatings, textiles, and surfaces that prevent infection and contamination.
September 2026
The DNA-based non-viral technologies market was valued at USD 5.60 billion in 2025, with leading companies including Thermo Fisher Scientific Inc., Lonza Group AG, Bio-Rad Laboratories, Inc., Promega Corporation, Qiagen N.V.
June 2026
The U.S. DNA nanotechnology market size is accounted to hit around USD 18.03 billion by 2035 increasing from USD 2.01 billion in 2025, with a CAGR of 24.53%.
April 2026
The U.S. targeted DNA RNA sequencing market size is accounted to hit around USD 27.72 billion by 2035 increasing from USD 4.80 billion in 2025, with a CAGR of 19.17%.
July 2025
The global viral vectors based gene therapy for non-human primates market size is estimated to hit around USD 5.46 billion by 2034 from USD 1.3 billion in 2024, with a CAGR of 15.44%.
June 2025
The global viral vectors for non human primates market size is estimated to hit around USD 397.87 million by 2034 from USD 145.8 million in 2024, at a CAGR of 10.56%.
September 2026
The Healthcare Consumables market was valued at USD 49.33 billion in 2026, with leading companies including boston scientific corporation, 3m, johnson & johnson, Medtronic, bd.
September 2026
The U.S. perfusion system market generated USD 7,35,773.48 thousand in 2026, with prominent U.S. perfusion system market companies including Medtronic plc, Getinge AB, LivaNova PLC.
September 2026
The U.S. central lab market generated USD 2.58 billion in 2026, with prominent U.S. central lab market companies including IQVIA, Labcorp, Quest Diagnostics, Thermo Fisher Scientific.
September 2026
The U.S. over the counter (OTC) drugs market size stood at USD 26 billion in 2026, with major U.S. over the counter (OTC) drugs companies including bayer ag, Pfizer, johnson & johnson services inc, Sanofi sa, Novartis ag.
September 2026
The U.S. brain computer interface market size stood at USD 703.70 billion in 2026, with major U.S. brain computer interface companies including neurosky, emotive, integra lifesciences, cortech solutions, cadwell industries.
August 2026
The U.S. dental equipment market reached USD 3.48 billion in 2026, with prominent companies such as U.S. dental equipment market leading the Midmark Corporation, Takara Belmont Corporation, Ultradent Products Inc., Millennium Dental Technologies.
September 2026
The U.S. clinical trial supply and logistics market was worth USD 1.66 billion in 2026, with key U.S. clinical trial supply and logistics market players including Marken, World Courier, Fisher Clinical Services.
September 2026
The bacterial and viral specimen collection market reached USD 59.95 billion in 2026, featuring leading while major growth segments span Puritan Medical Products companies such as Longhorn Vaccines and Diagnostics, LLC.
September 2026
The healthcare contract development and manufacturing organization market size reached USD 291.03 billion in 2026, with leading healthcare contract development and manufacturing organization market companies including onza Group Ltd., Covance Inc., Flex.
August 2026
The automation, digitization and robotics in cell and gene therapy manufacturing market reached USD 950.00 million in 2025, with key automation, digitization and robotics in cell and gene therapy manufacturing market companies including Thermo Fisher Scientific Inc., Sartorius AG, Danaher Corporation (Cytiva), Lonza Group AG.
August 2026
The U.S. complex and chronic condition management market size is valued at USD 7.47 billion in 2026 and is expected to reach over USD 18.33 billion by 2035, with a registered CAGR of 11.18%.
August 2026
By Payal Rabde - Aug 2026 - the global fill finish manufacturing market reached USD 20.00 billion in 2025 and is expected to expand at a CAGR of 9.10% until 2035.
August 2026
The electronic contract manufacturing and design services market size is estimated to hit around USD 1,544.97 billion by 2034 from USD 611.03 billion in 2024 with a CAGR of 9.72%.
August 2026
The global aluminum market size was USD 203.02 billion in 2026 and is projected to reach USD 347.29 billion by 2035 at a 6.16% CAGR, driven by rising demand from automotive, construction, packaging, and renewable energy industries.
August 2026
The U.S. behavioral health market is projected to grow from USD 94.82 billion in 2025 to USD 174.78 billion by 2035, registering a CAGR of 6.31%.
July 2026
Discover trends, key players, and growth drivers in the U.S. Investment Banking and Asset Management Market with in-depth market analysis.
June 2026
The global dental implants and prosthetics contract manufacturing market size is estimated to hit around USD 3.41 billion by 2035 increasing from USD 1.55 billion in 2025, with a CAGR of 8.20%.
June 2026
The U.S. health and wellness market size was evaluated at USD 2.31 trillion in 2025 and is predicted to surpass around USD 3.90 trillion by 2035, growing at a CAGR of 5.38%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com